Novartis and Roche win appeal against collective abuse fines
Shutterstock/testing
A French appellate court has quashed €444 million in fines levied by the country’s antitrust watchdog against Novartis and Roche, ruling that the drugmakers did not abuse their collective dominance by discouraging off-label prescriptions for a cheaper medicine.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Subscribe now